Viewing Study NCT04486833


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2025-12-26 @ 1:41 AM
Study NCT ID: NCT04486833
Status: RECRUITING
Last Update Posted: 2025-11-05
First Post: 2020-07-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Sponsor: Genprex, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module